Two Gene Variants Predict Who Benefits Most From Weight-Loss Injections

People carrying two genetic variants linked to appetite and digestion lose significantly more weight on injectable obesity drugs such as Wegovy and Mounjaro — and suffer fewer side effects — according to research published in Nature.